PDVAC Agenda 2020: Gonococcal vaccine Preferred Product Characteristics

Overview

2020 WHO Product Development for Vaccines Advisory Committee (PDVAC) Virtual Consultation 7: Gonococcal vaccine Preferred Product Characteristics: 4 December 2020

CHAIR: David Kaslow

The goal of this virtual session is to facilitate PDVAC review of the draft gonococcal vaccine PPC document, which has incorporated feedback from experts and the public. The intended outcome is to finalize the PPCs for publication, and to highlight critical aspects that require further consideration to facilitate future policy and implementation discussions.

Within this context, the objectives of this PDVAC meeting are to:

1. Review the rationale and context for developing gonococcal vaccine PPCs

2. Evaluate the draft PPC document tables and discuss the following gonococcal vaccine PPCs for an ideal gonococcal vaccine:
• vaccine indication(s)
• target population(s)
• vaccine delivery strategy(ies)
• route of administration
• duration of protection

3. Review additional considerations related to potential use of MenB vaccines for gonococcal infection if they are found to provide some cross-protection